The National Institutes of Health (NIH) invite applications for assays for high throughput screening to support the molecular libraries screening network (MLSCN).
This program announcement is an NIH Roadmap Initiative. The NIH Roadmap is an innovative approach to accelerate fundamental discovery and translate that knowledge into effective prevention strategies and new treatments. All NIH institutes and centers participate in Roadmap Initiatives.*
The goal of the MLSCN is to optimize and implement a variety of innovative biological, biophysical, and cell-based assays for biological targets or processes for which there are limited selective and potent small molecule modulators available to the public. This program announcement encourages applications from investigators who have developed innovative assays for use in both basic research and therapeutics development programs, and are interested in having the assays used within the MLSCN. The MLSCN intends to select approximately 100-200 assays per year to implement within the network of screening centers.
The MLSCN will provide assay implementation, a compound library, high throughput screening, optimization chemistry, and high throughput screening informatics.
For more information, potential applicants should contact Dr. Ingrid Li, Molecular Libraries Assay Access Team, NIH Molecular
Libraries & Imaging Roadmap, National Institute of Mental Health/NIH/DHHS, 6001 Executive Boulevard, Room 7185, Bethesda,
MD 20892; telephone: 301-443-5288;
fax: 301-402-4740; e-mail: email@example.com.
*For a more detailed description of this program announcement, please visit the NIH web site at: http://grants.nih.gov/grants/guide/pa-files/PAR-05-060.html.